The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

Tissue-engineered and chip-based models are changing how scientists study early cancer, leading to more accurate and humane ...

Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of ...

The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...

Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

Ribonucleic acid (RNA) is central to gene regulation, but accurately simulating its folding is a long-standing challenge in computational biology. In a recent study, Associate Professor Tadashi Ando ...